ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 77 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 2.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $387,000 | -27.0% | 379,837 | -1.1% | 0.04% | -35.0% |
| Q2 2021 | $530,000 | +67.7% | 384,201 | +106.4% | 0.06% | +15.4% |
| Q1 2021 | $316,000 | +24.9% | 186,161 | -8.7% | 0.05% | +26.8% |
| Q4 2020 | $253,000 | +12.4% | 203,830 | +28.9% | 0.04% | +7.9% |
| Q3 2020 | $225,000 | +675.9% | 158,174 | +570.6% | 0.04% | +137.5% |
| Q2 2020 | $29,000 | -78.5% | 23,586 | -79.4% | 0.02% | -52.9% |
| Q1 2020 | $135,000 | -44.0% | 114,437 | 0.0% | 0.03% | +21.4% |
| Q4 2019 | $241,000 | -47.9% | 114,437 | -4.8% | 0.03% | +7.7% |
| Q3 2018 | $463,000 | +155.8% | 120,158 | +123.9% | 0.03% | +188.9% |
| Q2 2018 | $181,000 | +60.2% | 53,658 | 0.0% | 0.01% | +50.0% |
| Q1 2018 | $113,000 | -41.1% | 53,658 | +215.6% | 0.01% | -60.0% |
| Q4 2013 | $192,000 | -42.7% | 17,000 | -45.3% | 0.02% | -42.3% |
| Q3 2013 | $335,000 | – | 31,100 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |